1.48
price down icon6.33%   -0.10
after-market アフターアワーズ: 1.50 0.02 +1.35%
loading
前日終値:
$1.58
開ける:
$1.57
24時間の取引高:
311.56K
Relative Volume:
1.47
時価総額:
$65.70M
収益:
-
当期純損益:
$-28.54M
株価収益率:
-2.3125
EPS:
-0.64
ネットキャッシュフロー:
$-22.72M
1週間 パフォーマンス:
-5.13%
1か月 パフォーマンス:
-10.84%
6か月 パフォーマンス:
-75.50%
1年 パフォーマンス:
-81.86%
1日の値動き範囲:
Value
$1.43
$1.59
1週間の範囲:
Value
$1.43
$1.65
52週間の値動き範囲:
Value
$1.40
$8.59

Essa Pharma Inc Stock (EPIX) Company Profile

Name
名前
Essa Pharma Inc
Name
セクター
Healthcare (1162)
Name
電話
(778) 331-0962
Name
住所
SUITE 720, VANCOUVER, BC
Name
職員
35
Name
Twitter
@essapharma
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
EPIX's Discussions on Twitter

EPIX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
EPIX
Essa Pharma Inc
1.48 65.70M 0 -28.54M -22.72M -0.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-04 ダウングレード Jefferies Buy → Hold
2024-11-04 ダウングレード Oppenheimer Outperform → Perform
2024-11-04 ダウングレード Piper Sandler Overweight → Neutral
2023-06-26 再開されました Oppenheimer Outperform
2021-03-04 開始されました Piper Sandler Overweight
2021-01-11 繰り返されました H.C. Wainwright Buy
2020-11-02 開始されました Jefferies Buy
2019-10-25 開始されました Oppenheimer Outperform
すべてを表示

Essa Pharma Inc (EPIX) 最新ニュース

pulisher
Apr 01, 2025

We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate - Yahoo Finance

Apr 01, 2025
pulisher
Mar 25, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 25, 2025
pulisher
Mar 25, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Markets Insider

Mar 25, 2025
pulisher
Mar 25, 2025

EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Mar 25, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law - GlobeNewswire

Mar 24, 2025
pulisher
Mar 24, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Business Wire

Mar 24, 2025
pulisher
Mar 24, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pen - GuruFocus

Mar 24, 2025
pulisher
Mar 24, 2025

ESSA Pharma Inc. Securities Fraud Class Action Lawsuit - GlobeNewswire

Mar 24, 2025
pulisher
Mar 23, 2025

Shareholders that lost money on ESSA Pharma Inc.(EPIX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

EPIX IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire

Mar 23, 2025
pulisher
Mar 23, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewswire Inc.

Mar 23, 2025
pulisher
Mar 23, 2025

ESSA Pharma Inc. Faces Securities Fraud Class Action Over Alleged Investor Misleading Statements - Apna Kal

Mar 23, 2025
pulisher
Mar 22, 2025

Investors in ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX - ACCESS Newswire

Mar 22, 2025
pulisher
Mar 21, 2025

Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

ESSA Pharma Inc. (NASDAQ: EPIX) Investor Alert: Deadline in Lawsuit on March 25, 2025 - openPR

Mar 20, 2025
pulisher
Mar 20, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against ESSA, Cardlytics, Novo Nordisk, and Crocs and Encourages Investors to Contact the Firm - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 25 Deadline in Securities Class ActionEPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of - GlobeNewswire

Mar 20, 2025
pulisher
Mar 20, 2025

The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – EPIX - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

EPIX Lawsuit Alert! Class Action Lawsuit Against ESSA Pharma, Inc. - TipRanks

Mar 20, 2025
pulisher
Mar 19, 2025

EPIX Investors Have Final Opportunity Approaching to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 19, 2025
pulisher
Mar 18, 2025

EPIX Deadline: EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Levi & Korsinsky Notifies Shareholders of ESSA Pharma - GlobeNewswire

Mar 18, 2025
pulisher
Mar 17, 2025

EPIX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - StreetInsider.com

Mar 17, 2025
pulisher
Mar 17, 2025

2025-03-17 | INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain OfficersEPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

ESSA Pharma Inc. Class Action: The Gross Law Firm Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025EPIX - PR Newswire

Mar 17, 2025
pulisher
Mar 16, 2025

2025-03-16 | ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your RightsEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 16, 2025
pulisher
Mar 16, 2025

EPIX Stockholders Have Opportunity to Lead ESSA Pharma Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider

Mar 16, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Mar 15, 2025
pulisher
Mar 14, 2025

Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineEPIX - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages - GlobeNewswire

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - GlobeNewswire Inc.

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

2025-03-14 | Investors who lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class ActionEPIX | NDAQ:EPIX | Press Release - Stockhouse Publishing

Mar 14, 2025
pulisher
Mar 14, 2025

EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 14, 2025
pulisher
Mar 13, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March ... - The Bakersfield Californian

Mar 13, 2025
pulisher
Mar 13, 2025

ESSA Pharma Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 25, 2025 Deadline to file Lead Plaintiff Motion - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

EPIX LAWSUIT ALERT: Levi & Korsinsky Notifies ESSA Pharma - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

EPIX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - PR Newswire

Mar 13, 2025
pulisher
Mar 13, 2025

March 25, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against EPIX - PR Newswire

Mar 13, 2025
pulisher
Mar 12, 2025

EPIX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ESSA Pharma Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider

Mar 12, 2025
pulisher
Mar 12, 2025

Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse Publishing

Mar 12, 2025
pulisher
Mar 12, 2025

ROSEN, A LEADING LAW FIRM, Encourages ESSA Pharma Inc. - GlobeNewswire

Mar 12, 2025
pulisher
Mar 11, 2025

Levi & Korsinsky Notifies Shareholders of ESSA Pharma Inc. (EPIX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 11, 2025

Essa Pharma Inc (EPIX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):